StevenJKulbackMD

Internal Medicine • Birmingham, AL

Physician

Join to view full profile

Dr. Kulback is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kulback's full profile

Already have an account?

Office
3536 Vann Rd
Ste B
Birmingham, AL 35235
Phone+1 205-838-3200

Fax+1 205-838-6981

Education & Training

Physicians Medical Center CarrawayResidency, Internal Medicine, 1980 - 1982
Physicians Medical Center CarrawayResidency, Internal Medicine, 1979 - 1979
University of Tennessee Health Science Center College of MedicineClass of 1978

Certifications & Licensure

FL State Medical License 2016 - 2027
AL State Medical License 1980 - 2025
AR State Medical License 1982 - 1996
TN State Medical License 1979 - 1995
LA State Medical License 1984 - 1985
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Diabetes Recognition Program National Committee for Quality Assurance, 2014-2017
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012, 2014

Clinical Trials

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate Start of enrollment: 2005 Dec 01
Completed
Phase 3
GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS) Start of enrollment: 2006 Oct 01
Completed
Phase 4
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Start of enrollment: 2006 Dec 31
Completed
Phase 3
Levitra® - Real Life Safety and Efficacy of Levitra Start of enrollment: 2003 Oct 01
Completed
Phase 4
Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men Start of enrollment: 2008 Jun 01
Completed
Phase 2
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial Start of enrollment: 2008 Nov 01
Completed
Phase 3
Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2008 Nov 01
Completed
Phase 1, Phase 2
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Start of enrollment: 2010 Nov 11
Completed
Phase 3
Efficacy and Safety of AQX-1125 in Unstable COPD Start of enrollment: 2013 Oct 01
Completed
Phase 2
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men Start of enrollment: 2017 Jul 05
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

34 citations
Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation.
Anthony Yin, Michelle Htun, Ronald S. Swerdloff, Maruja Diaz-Arjonilla, Robert E Dudley
Journal of Andrology. 2012-03-04
5 citations
Communicating With Deaf Patients
Steven J. Kulback
JAMA. 1995-09-13